EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Fundamental Analysis

BIT:1EW • US28176E1082

65.35 EUR
-5.41 (-7.65%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

Overall 1EW gets a fundamental rating of 7 out of 10. We evaluated 1EW against 65 industry peers in the Health Care Equipment & Supplies industry. 1EW gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, 1EW is valued expensive at the moment. With these ratings, 1EW could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • 1EW had positive earnings in the past year.
  • In the past year 1EW had a positive cash flow from operations.
  • 1EW had positive earnings in each of the past 5 years.
  • 1EW had a positive operating cash flow in each of the past 5 years.
1EW.MI Yearly Net Income VS EBIT VS OCF VS FCF1EW.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • 1EW's Return On Assets of 10.31% is amongst the best of the industry. 1EW outperforms 89.55% of its industry peers.
  • 1EW's Return On Equity of 13.40% is fine compared to the rest of the industry. 1EW outperforms 77.61% of its industry peers.
  • 1EW's Return On Invested Capital of 12.50% is amongst the best of the industry. 1EW outperforms 89.55% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1EW is significantly above the industry average of 9.73%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 12.5%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1EW.MI Yearly ROA, ROE, ROIC1EW.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 23.25%, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
  • 1EW's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1EW (27.73%) is better than 97.01% of its industry peers.
  • 1EW's Operating Margin has been stable in the last couple of years.
  • 1EW's Gross Margin of 78.19% is amongst the best of the industry. 1EW outperforms 92.54% of its industry peers.
  • 1EW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
1EW.MI Yearly Profit, Operating, Gross Margins1EW.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1EW is still creating some value.
  • Compared to 1 year ago, 1EW has less shares outstanding
  • Compared to 5 years ago, 1EW has less shares outstanding
  • Compared to 1 year ago, 1EW has an improved debt to assets ratio.
1EW.MI Yearly Shares Outstanding1EW.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1EW.MI Yearly Total Debt VS Total Assets1EW.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 11.49 indicates that 1EW is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.49, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
  • The Debt to FCF ratio of 1EW is 0.75, which is an excellent value as it means it would take 1EW, only 0.75 years of fcf income to pay off all of its debts.
  • 1EW has a Debt to FCF ratio of 0.75. This is amongst the best in the industry. 1EW outperforms 91.04% of its industry peers.
  • 1EW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • 1EW has a better Debt to Equity ratio (0.06) than 85.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 11.49
ROIC/WACC1.25
WACC9.99%
1EW.MI Yearly LT Debt VS Equity VS FCF1EW.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • 1EW has a Current Ratio of 4.00. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.00, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
  • 1EW has a Quick Ratio of 3.29. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.29, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
1EW.MI Yearly Current Assets VS Current Liabilites1EW.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for 1EW have decreased by -3.75% in the last year.
  • 1EW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
  • 1EW shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
  • The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.40% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1EW.MI Yearly Revenue VS Estimates1EW.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
1EW.MI Yearly EPS VS Estimates1EW.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 29.84, which means the current valuation is very expensive for 1EW.
  • 1EW's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, 1EW is valued at the same level.
  • With a Price/Forward Earnings ratio of 25.83, 1EW can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as 1EW.
  • 1EW's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.02.
Industry RankSector Rank
PE 29.84
Fwd PE 25.83
1EW.MI Price Earnings VS Forward Price Earnings1EW.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1EW is valued a bit more expensive than the industry average as 61.19% of the companies are valued more cheaply.
  • 1EW's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.74
EV/EBITDA 22.46
1EW.MI Per share data1EW.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EW does not grow enough to justify the current Price/Earnings ratio.
  • 1EW has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)23.47
PEG (5Y)4.18
EPS Next 2Y6.53%
EPS Next 3Y7.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1EW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDWARDS LIFESCIENCES CORP

BIT:1EW (2/10/2026, 7:00:00 PM)

65.35

-5.41 (-7.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap37.92B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target82.88 (26.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)1.89%
PT rev (3m)7%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-1.76%
EPS NY rev (1m)0.84%
EPS NY rev (3m)5.07%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)3.04%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)3.76%
Valuation
Industry RankSector Rank
PE 29.84
Fwd PE 25.83
P/S 7.58
P/FCF 55.74
P/OCF 43.83
P/B 4.37
P/tB 6.1
EV/EBITDA 22.46
EPS(TTM)2.19
EY3.35%
EPS(NY)2.53
Fwd EY3.87%
FCF(TTM)1.17
FCFY1.79%
OCF(TTM)1.49
OCFY2.28%
SpS8.63
BVpS14.96
TBVpS10.71
PEG (NY)23.47
PEG (5Y)4.18
Graham Number27.15
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 12.5%
ROICexc 18.63%
ROICexgc 29.56%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 11.49
F-Score6
WACC9.99%
ROIC/WACC1.25
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.


What is the valuation status of EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.


How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.


What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 29.84 and the Price/Book (PB) ratio is 4.37.


What is the expected EPS growth for EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 1.27% in the next year.